--- a
+++ b/clusters/9knumclustersv2/clust_1463.txt
@@ -0,0 +1,94 @@
+Positive human immunodeficiency virus (HIV) or human T-cell lymphotrophic virus (HTLV)- serology
+Subject has an active infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), or human T-lymphotropic virus (HTLV) as defined below:
+Positive for HIV, hepatitis B, hepatitis C, syphilis or human T Cell leukemia virus (HTLV).
+Negative human T-lymphotropic virus (HTLV)- and  antibodies.
+EXCLUSION - PROCUREMENT: Active infection with human immunodeficiency virus (HIV) or human T-lymphotropic virus (HTLV)
+EXCLUSION - PROCUREMENT: Active infection with human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis B virus (HBV), hepatitis C virus (HCV) (can be pending at this time)
+PROCUREMENT EXCLUSION: Active infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus (HTLV) (can be pending at this time)
+Positive for HIV, hepatitis B, hepatitis C, syphilis or human T cell leukemia virus (HTLV).
+No known history of human immunodeficiency virus (HIV)  and , human T-cell lymphotropic virus (HTLV)-I/II, and hepatitis B and C
+Donors who are HIV-, HIV-, human T-lymphotropic virus (HTLV)-, HTLV- seropositive or with active hepatitis B or hepatitis C virus infection
+PART I: Negative serology for anti-human immunodeficiency virus (HIV)-/ and anti-human T-lymphotropic virus (HTLV) /
+Patients must have serum antibodies directed to human T-cell lymphotropic virus (HTLV)-
+Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-)
+Seropositivity for human T-lymphotropic virus type  (HTLV-).
+Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-)
+Donors who are human immunodeficiency virus (HIV)-, HIV-, human T-lymphotropic virus (HTLV)-, HTLV- seropositive or with active hepatitis B or hepatitis C virus infection
+Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-) seropositive status
+Known infection with Human Immunodeficiency Virus (HIV) or Human T-lymphotropic Virus  (HTLV-).
+Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-) seropositive status
+DONOR: Active hepatitis, positive for human T-cell lymphotropic virus (HTLV), or HIV on donor viral screen
+Seronegative for human T-cell lymphotropic virus type  (HTLV-)
+Positive results for the human T-lymphotrophic  virus (HTLV-)
+Patients with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-) are not eligible
+DONOR: Chronic viral infection including active hepatitis B, hepatitis C, HIV, or human T-lymphotropic virus (HTLV)-/
+DONOR: Positive for hepatitis, human T-lymphotropic virus (HTLV), or HIV on donor viral screen
+Any positive history for human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), human T-cell lymphotropic virus (HTLV), hepatitis B or hepatitis C virus indicating acute or chronic infection
+No known history of human immunodeficiency virus (HIV)  and , human T-lymphotropic virus (HTLV)-, or active hepatitis B or hepatitis C
+Human immunodeficiency virus (HIV), human T-cell lymphotropic virus type  (HTLV-), hepatitis B virus (HBV), and hepatitis C virus (HCV) negative
+Subject has positive test result at the screening visit for one or more of the following:\r\n* Human T-cell lymphotropic virus (HTLV-/)\r\n* Anti-human immunodeficiency virus (HIV)  antibody (alpha-HIV-)
+EXCLUSION CRITERIA FOR ENROLLMENT: Human immunodeficiency virus (HIV)-/ or human T-cell lymphotropic virus (HTLV)-/ positivity
+Human immunodeficiency virus (HIV) or human T-cell leukemia virus type (HTLV)/HTLV (seropositivity and/or polymerase chain reaction [PCR] positivity)
+Active symptomatic fungal, bacterial and/or viral infection including evidence of infection with human immunodeficiency virus (HIV), human T-cell leukemia virus  (HTLV-) seropositive status
+Subject has positive test result at the screening visit for one or more of the following: human T-lymphotropic virus (HTLV)-/ and/or anti-human immunodeficiency virus (HIV)  antibody (alpha-HIV-)
+Known history of infection with human immunodeficiency virus (HIV) or human T cell leukemia virus  (HTLV-)
+Positive for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-lymphotropic virus  (HTLV) and/or HTLV
+Seroreactivity for human immunodeficiency virus (HIV), human T-lymphotropic virus type I (HTLV I) or II, hepatitis B virus (HBV), hepatitis C virus (HCV)
+Uncontrolled infection, including human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV)-, hepatitis B or hepatitis C viremia
+History of human immunodeficiency virus (HIV), hepatitis B, hepatitis C and human t-lymphotropic virus (HTLV)
+Active infection with human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV)
+History of positive serology tests for human immunodeficiency virus (HIV)  and , human T cell lymphotropic virus (HTLV)-, hepatitis B and C
+DONOR: Must be free from risk factors for, and no clinical evidence of, infection due to relevant communicable disease agents and diseases including: human immunodeficiency virus; hepatitis B virus; hepatitis C virus; human transmissible spongiform encephalopathy, including Creutzfeldt-Jakob disease; treponema pallidum and human T-cell lymphotropic virus (HTLV)  and 
+Known infection with human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV)-I, hepatitis B, or hepatitis C
+DONOR: HIV or human T-lymphotropic virus (HTLV) seropositive
+Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV)-I/II
+Active infection with human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), hepatitis B virus (HBV), hepatitis C virus (HCV) (can be pending at this time)
+DONOR: Human T-lymphotropic virus (HTLV)/HIV(+) or hepatitis B or C antigen(+) donors
+Active infection with human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), human T-cell lymphotropic virus (HBV), hepatitis C virus (HCV) (can be pending at this time)
+Patient seropositive for human immunodeficiency virus (HIV)-I/II; human t-lymphotrophic virus (HTLV) -I/II
+Seropositivity for human T-lymphotropic virus type  (HTLV-)
+Immunocompromised patients (other than that related to the use of corticosteroids) including patients known to be human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), hepatitis B (HepB), or hepatitis C (HepC) positive
+Human immunodeficiency virus (HIV)-/HIV- or human T-lymphotropic virus (HTLV)-/HTLV- seropositivity
+Patients with evidence of human immunodeficiency virus (HIV) seropositivity and/or positive polymerase chain reaction (PCR) assay, human T-cell leukemia virus type (HTLV)/HTLV seropositivity
+DONOR: Positive or reactive test results for Food and Drug Administration (FDA)-mandated relevant communicable diseases (HIV, hepatitis B [hep B], hepatitis C, human T-cell lymphotropic virus [HTLV], Syphilis, Trypanosoma [T.] cruzi)
+Human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV) or human T-lymphotropic virus (HTLV) I/II infections
+Active infection with human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis B virus (HBV), hepatitis C virus (HCV) (can be pending at this time)
+Known human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV) infection
+Exclusions for the leukapheresis procedure (this can be performed at a later time of symptoms resolve): \r\n* Infection, with or without antibiotic treatment\r\n* Recent hepatitis exposure (hepatitis B or C antigenemia)\r\n* Pregnancy or nursing\r\n* HIV or human T-lymphotropic virus (HTLV) infection\r\n* Positive result on standard test for syphilis (STS)
+Participants with known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-)
+Participants with known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus- (HTLV-)
+Patient is positive for human immunodeficiency virus (HIV) or human T-cell lymphotropic virus- (HTLV-)
+Immunocompromised patients (other than that related to the use of corticosteroids) including patients known to be human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), hepatitis B (HepB), or hepatitis C (HepC) positive
+DONOR: Donors who are HIV-, HIV-, human T-lymphotropic virus (HTLV)-, HTLV- seropositive or with active hepatitis B or hepatitis C virus infection
+Seroreactivity for human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV) I or II, hepatitis B virus (HBV), hepatitis C virus (HCV)
+Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV)-I/II
+Known or tests positive for human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV-), hepatitis B or hepatitis C.
+Active infections including human T-lymphotropic virus (HTLV)  and , and human immunodeficiency virus (HIV)  and 
+Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-lymphotrophic virus (HTLV)-I/II
+Known infection with human immunodeficiency virus (HIV), human T-lymphotropic virus  (HTLV-I), hepatitis B, or hepatitis C
+MATCHED RELATED DONOR: Donors must be human immunodeficiency virus (HIV) negative, human T-cell lymphotropic virus (HTLV) negative, hepatitis B virus surface antigen (HBsAg) negative
+Positive test results for human immunodeficiency virus (HIV), human T-lymphotropic virus  (HTLV), hepatitis C or chronic hepatitis B
+Seronegativity for human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), hepatitis
+Human T-lymphotropic virus (HTLV)-/
+Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV) -I/II
+Positive test results for human T-lymphotropic virus type I (HTLV ) virus in endemic countries
+DONOR: Virology testing including cytomegalovirus (CMV), human immunodeficiency virus (HIV), EpsteinBarr virus (EBV), human T-lymphotropic virus (HTLV), rapid plasma reagin (RPR), hepatitis A, B and C will be performed within  days of donation
+DONOR: Human immunodeficiency virus (HIV) or human T-lymphotrophic virus (HTLV) infection
+HIV or human T-lymphotropic virus (HTLV) I/II positive, hepatitis C or chronic active hepatitis B
+Known human immunodeficiency virus (HIV) or human T-lymphotropic virus, type I (HTLV-I) positive status
+Human immunodeficiency virus (HIV) or Human T Cell Lymphotropic Virus  (HTLV-) infection
+DONOR: not human immunodeficiency virus (HIV)-, HIV-, hepatitis C virus (HCV), hepatitis B core or human T-lymphotropic virus (HTLV)-I/II seropositive; hepatitis B surface antigen (HB S ag) (-); meet other infectious disease screening criteria utilized by NBAH Blood Center
+Human immunodeficiency virus (HIV) or human T-lymphotropic virus (HTLV)-I/II
+Active symptomatic fungal, bacterial and/or viral infection including positive serologies for human immunodeficiency virus (HIV), H\\human T-lymphotropic virus  (HTLV-), , hepatitis C virus (HCV) or hepatitis B virus (HBV) (acute or chronic infection based on Center for Disease Control and Prevention [CDC] guidelines) within  days of registration; (antibody, antigen and nucleic acid tests acceptable, depending on institutional standards)
+Human immunodeficiency virus (HIV) infection or Human T Cell Lymphotropic Virus  (HTLV-) infection
+Has a known human T-lymphotropic virus type  (HTLV) infection
+Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus  (HTLV-)
+Known infection with human immunodeficiency virus (HIV) or Human T-Cell Leukemia Virus  (HTLV-) seropositive status
+Known history of human immunodeficiency virus (HIV) seropositive status or known infection with human T-cell leukemia virus  (HTLV-) virus
+Uncontrolled infection, including human immunodeficiency virus (HIV), human T-cell lymphotropic virus type  (HTLV-), hepatitis B or hepatitis C viremia
+No known history of human immunodeficiency virus (HIV) /, human T-lymphotropic virus (HTLV)-I/II
+DONOR: Human T-cell lymphotropic virus (HTLV)/human immunodeficiency virus (HIV)(+) or hepatitis B or C antigen(+) donors
+Patients seropositive for Human T-Lymphotrophic Virus (HTLV)-I or -II
+Positive serology for human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV) at any time prior to enrollment;
+Positive viral test of the donor for HIV-, HIV-, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum, human T-lymphotropic virus (HTLV)  (if tested), HTLV- (if tested), West Nile virus (WNV; if tested), or Zika virus (if tested)
+The patient has known positive human immunodeficiency virus (HIV) or known active human t-cell lymphotropic virus (HTLV) I/II disease, whether on treatment or not.